Similar articles

• HIV-1 drug resistance testing. IAPAC sessions 2001, July 18-19, 2001 - Chicago.

  Simon VA; Aaron Diamond AIDS Research Center, New York, USA. Simon VA, et al. IAPAC Mon. 2001 Aug;7(8):235-7. IAPAC Mon. 2001. PMID: 11708276 No abstract available.
• HIV resistance testing in clinical practice: a Qaly-fied success.

  Saag MS. Saag MS. Ann Intern Med. 2001 Mar 20;134(6):475-7. doi: 10.7326/0003-4819-134-6-200103200-00012. Ann Intern Med. 2001. PMID: 11255523 No abstract available.
• The association of HIV susceptibility testing with survival among HIV-infected patients receiving antiretroviral therapy: a cohort study.

  Palella FJ Jr, Armon C, Buchacz K, Cole SR, Chmiel JS, Novak RM, Wood K, Moorman AC, Brooks JT; HOPS (HIV Outpatient Study) Investigators. Palella FJ Jr, et al. Ann Intern Med. 2009 Jul 21;151(2):73-84. doi: 10.7326/0003-4819-151-2-200907210-00003. Ann Intern Med. 2009. PMID: 19620160
• [The impact of resistance testing of HIV-1 to the HIV clinical setting in Japan].

  Yamamoto Y. Yamamoto Y. Nihon Rinsho. 2002 Apr;60(4):769-74. Nihon Rinsho. 2002. PMID: 11968786 Review. Japanese.
• The REVAMP trial to evaluate HIV resistance testing in sub-Saharan Africa: a case study in clinical trial design in resource limited settings to optimize effectiveness and cost effectiveness estimates.

  Siedner MJ, Bwana MB, Moosa MS, Paul M, Pillay S, McCluskey S, Aturinda I, Ard K, Muyindike W, Moodley P, Brijkumar J, Rautenberg T, George G, Johnson B, Gandhi RT, Sunpath H, Marconi VC. Siedner MJ, et al. HIV Clin Trials. 2017 Jul;18(4):149-155. doi: 10.1080/15284336.2017.1349028. Epub 2017 Jul 18. HIV Clin Trials. 2017. PMID: 28720039 Free PMC article. Review.